Board Simulation Potpourri - Cleveland Clinic Center for Continuing

Board Simulation Potpourri
Christian Nasr, MD, FACE, FACP
Endocrinology & Metabolism Institute
Cleveland Clinic
Intensive Review of Endocrinology & Metabolism – September 2014
Question 1
1. Which drug does not inhibit cortisol biosynthesis?
A. Aminoglutethimide
B.
Etomidate
C.
Ketoconazole
D. Rifampin
E.
Metyrapone
F.
Suramin
Question 2
2. Among the following presentations of differentiated
thyroid carcinoma, which one is associated with a
relatively good prognosis?
A. Rapidly expanding neck mass in an 80-year old man
B. Metastatic axillary adenopathy
C. Diffuse lung uptake on whole body radioiodine scan
with normal chest CT in a 20-year old woman
D. Metastases visible on FDG-PET but not on
radioiodine whole body scan
E. Tall-cell variant of thyroid carcinoma
Question 3
3. Which of these cancers has the strongest
link with GH excess (acromegaly)?
A.
B.
C.
D.
Breast cancer
Lung cancer
Prostate cancer
Colorectal cancer
Question 4
4. Which of these cancers has the weakest
link with GH excess (acromegaly)?
A.
B.
C.
D.
Breast cancer
Lung cancer
Prostate cancer
Colorectal cancer
Question 5
Which statement regarding testicular
dysfunction in HIV-infected patients is
most accurate?
A.
Hypogonadism is most often primary
B.
Megestrol acetate used in AIDS wasting may inhibit critical
enzymes in testicular steroidogenesis and lead to
hypogonadism
C.
Levels of sex hormone–binding globulin are usually
decreased in HIV-infected patients
D.
Physiologic testosterone replacement results in increased
lean body mass, improved quality of life, and reduction in
indices of depression in HIV-infected men with
hypogonadism
Question 6
• A 75-yo man was referred to you because of fatigue,
weight loss and generalized aches for the last two
years. He has a history of a “stress fracture” of his foot
1.5 years ago. Bone density ordered recently by his
podiatrist showed osteoporosis in the hip and
osteopenia in the lumbar spine. He has a
subcutaneous nodule on his right shin.
• Lab results:
PTH = 78 pg/mL (Nl 10-60)
Calcium = 9.8 mg/dL (Nl 8.5-10.5)
Phosphorus 1.3 mg/dL (Nl 2.5-4.5)
Vitamin D 25OH was 31 ng/mL (Nl 30-100)
6. What findings are most consistent with his
presentation?
A.
Low vitamin D 1,25; high urine phosphorus; high serum
FGF-23
B.
High urine calcium; high vitamin D 1,25; high serum FGF23
C.
Low urine calcium; low urine phosphorus; low serum
FGF-23
D.
Low vitamin D 1,25; low urine phosphorus; low serum
FDG-23
Question 7
7. What is the correct statement regarding familial
dysalbuminemic hyperthyroxinemia:
A. The albumin variant has a high affinity for
T4 and T3
B.
Free T4 index (FTI) is normal
C.
TSH is suppressed
D. Free T4 is normal
E.
It is transmitted as an autosomal recessive
trait
Question 8
A 28-year old man is brought in by his wife because of cognitive changes, short term
memory deficit, involuntary movements, weakness and numbness of his legs with
recent loss of balance leading to falls. The symptoms have been progressively
worsening over a few months. He had to stop working recently. Magnetic resonance
imaging of the brain revealed patchy white matter changes. His wife noted that his
skin has been a little darker and that he has had a decreased libido and erections. He
has lost some weight and his appetite seems to have decreased.
Baseline serum cortisol was 7 ug/dL and ACTH was 150 pg/mL. After the intravenous
injection of 250 mcg of cosyntropin, his serum cortisol rose to 16 ug/dL at 30 minutes
and 19 ug/dL at 60 minutes. There is no family history of similar problems.
You made the correct diagnosis of this condition.
Which characteristic is true about this condition?
A.
B.
C.
D.
E.
It is autosomal recessive
There is decreased synthesis of very-long chain fatty acids
The defective gene is ABCD1
Plasmapheresis will stop the progression
The abnormality is at the neuromuscular junction
Question 9
A 26 year old man is referred to you for lack of sexual development. He has been dealing with
this since teenage. It became a problem when he recently met a partner and sought medical
help. He is of normal height but he has a enuchoid habitus. He has no gynecomastia, penis is
small and testicles are in the scrotum but they are very small. The patient cannot smell coffee or
vanilla.
Lab results:
Normal chemistry panel
Serum PRL = 12 ng/mL
Serum TSH = 0.44 mU/L
Serum Free T4 = 1.2 ug/dL
Serum total testosterone 20 ng/mL
Serum LH = 0.4 IU/L
Serum FSH = 0.4 IU/L
Magnetic resonance imaging:
Normal brain and pituitary
9.
Which one of the following characteristics is true
about the patient’s condition?
A. This patient has seminiferous tubular dysgenesis
B. There is KAL1 mutation
C. There is FGFR1 mutation
D. There is a high risk of aortic valvular disease and
ruptured berry aneurysms
E. There is a high risk of acute leukemia,
lymphoma, and midline germ cell tumors
Question 10
One of your patients with uncontrolled type-2 diabetes mellitus comes
to see you because of an ulcer that she has had on the bottom of her
left foot over the first metatarsal head for 4-6 weeks. Her typical
glycated hemoglobin is around 9%. On exam, she has a deep ulcer that
you were able to probe to the bone. She has poor sensation in her
feet and there is mild redness around the ulcer. There is foul smelling
discharge on the sock.
Lab test results:
WBC = 12,500/microL
Sed rate = 50 mm/hr
You wanted to confirm osteomyelitis to decide how long to treat her
with antibiotics.
10. Which test has the best specificity for the
diagnosis of osteomyelitis?
A. Plain radiograph of the foot
B. Indium-labeled WBC scan
C. Triple-phase bone scan
D. MRI with contrast
E. Blood culture
Question 11
A 62 year old woman is referred to you by her primary care physician
for suspicion of a neuroendocrine tumor. She has had intermittent
diarrhea for 15 years which was diagnosed as irritable bowel
syndrome. For the last 3 years she has had episodes of spontaneous
facial flushing with identifiable triggers lasting 10-20 minutes. She
has no respiratory symptoms. Her physician ordered lab tests that
showed the following:
CBC = normal
Hepatic panel = normal
Urine 5-HIAA = 350 mg/24 hr (Normal <30 mg/24 hr)
TSH = 0.40 mU/L (Normal 0.40-5.50)
T4, free = 1.4 ng/dL (Normal 0.7 – 1.8)
11. What is the next best diagnostic test in this
patient?
A. MRI of the chest and abdomen
B. Somatostatin-receptor whole body
Scintigraphy
C. Measurement of plasma 5-Hydroxytrytophan
D. Radioactive iodine uptake and scan
E. Repeat urine measurement of 5-HIAA with
restriction of foods and drugs that can cause
elevation
Question 12
You are asked to see a 63-year old woman who has been hospitalized for the last 2 weeks with multiple
painful skin ulcers occurring on the low abdomen and thighs. You tell the attending that you are not a
dermatologist but he insists that he wants your help because he is suspecting that her condition could
have an endocrine basis. You find out that she has had end-stage renal disease (ESRD) for which she has
been receiving hemodialysis. The ESRD complicated her type-2 diabetes mellitus. The ulcers are wide
and deep. The floor is covered by thin green material. Some of the areas are covered by thick black
eschars. The surrounding skin appears red and thickened.
Lab results:
Serum creatinine = 5.3 mg/dL (normal 0.6-1.3)
Serum Calcium = 8.3 mg/dL (normal 8.5-10.3)
Serum PTH = 300 pg/mL (normal 15-55)
Serum phosphorus = 6.2 mg/dL (nl 2.5-4.5)
WBC = 14,000/uL
Soft tissue radiographs of the leg:
Calcifications of subcutaneous arteries
12. What is the most correct statement to tell to the
attending physician?
A. Parathyroidectomy will cure the cutaneous lesions and improve
survival
B.
Changing to a non-calcium containing phosphate binder will
likely improve the cutaneous lesions
C.
Hyperbaric oxygen therapy improves the lesions in most patients
D. Oral sodium thiosulphate can improve the lesions
E.
The prognosis is very bad and no single intervention has proven
effective. Supportive therapy, selective debridement and
preventing infection are crucial
Question 13
You see your 58-year old man with type-2 diabetes mellitus during an office follow-up
visit. He had coronary revascularization 12 months ago. His BMI is 40 kg/m2 and he
continues to struggle with following a low-calorie diet. He has not cut back on
cigarette smoking. His blood pressure averages 140/95 mmHg despite triple-therapy.
His last LDL-cholesterol was 120 mg/dL and he has cut back significantly on his
consumption of animal fat compared to 6 months ago and he has been taking his 20
mg of pravastatin regularly.
Lab test results a week ago:
HbA1c = 8.2%
Total cholesterol = 157 mg/dL
LDL-cholesterol = 90 mg/dL
HDL-cholesterol = 35 mg/dL
Triglycerides = 160 mg/dL
Fasting glucose = 170 mg/dL
TSH = 2.230 mU/L
Urine albumin/creatinine = 110 ug/mg
13. What is the best approach to lipid management in
this patient?
A. Add fenofibrate 145 mg daily
B. Increase pravastatin to 40 mg daily
C. Change from pravastatin to Lipitor 20 mg daily
D. Change from pravastatin to rosuvastatin 10 mg
daily
E. Add ezetimibe 10 mg daily
Question 14
A 50 year old former commercial sex worker was referred to you for
progressive generalized weakness, poor appetite and 20-lb weight loss
over 2 months. She has been nauseated and lightheaded. She has just
finished a course of treatment for histoplasmosis. You recorded
orthostatic hypotension and on examination you noticed increased
skin and mucosal pigmentation.
Lab results:
ACTH = 250 pg/mL (normal 10-55)
Cortisol = 2.5 ug/dL (drawn in AM)
Serum potassium = 5.5 mEq/L
Serum sodium = 130 mEq/L
Serum calcium = 10.9 mg/dL
14. What is the best explanation for the
patient’s problem?
A. Bilateral adrenal hemorrhage
B.
Only the adrenal cortex is affected by the infectious process
because of the nature of the vascular supply to the gland
C.
The patient may have an “acquired” form of glucocorticoid
resistance due to reduced glucocorticoid receptor affinity
D. The antifungal treatment precipitated the current problem
E.
The most common cause of adrenal gland destruction in AIDS
patients is Mycobacterium Avium-intracellulare
Question 15
A 44 year old man was recently diagnosed with medullary thyroid cancer
(MTC) on FNA of a right thyroid nodule. He underwent total thyroidectomy
with ipsilateral level VI dissection. On histology he was found to have a 2.5
cm MTC with invasion of the perithyroidal tissues and 6/6 positive lymph
nodes without extranodal extension. Preoperatively he had had a normal
chest radiograph and plasma metanephrines. On his 3-month postoperative
visit, he is on levothyroxine 125 mcg daily and he has the following findings:
Lab results:
TSH = 1.5 mIU/L
Calcitonin = 210 pg/mL (normal <16)
Calcium = 8.2 mg/dL
Neck ultrasound:
No evidence of disease
15. What is the best next step in this patient?
A.
Reassure the patient that his prognosis is good, increase the
levothyroxine to 137 mcg to suppress the TSH to 0.1-0.3
mIU/L and have him return for a 3-month follow up
B.
Reassure the patient that there is no need to be alarmed and
repeat the calcitonin in 2-3 months
C.
He should undergo additional imaging to evaluate for distant
metastases
D. He should undergo external beam radiation to the right neck
E.
The patient should be considered for inclusion in a clinical trial
Question 16
You inherit an 18 year old man from his pediatric endocrinologist. He has a
history of whole-brain irradiation for a malignant tumor when he was 11 and
developed growth hormone deficiency. He was maintained on human growth
hormone treatment (hGH) and achieved satisfactory growth. He and his
mother had questions regarding the benefits and risks of continuing hGH.
What is the best answer to give to this patient?
A.
Continuing hGH will increase the risk of brain tumor recurrence
B.
HGH treatment may increase the risk of radiation-induced second
tumor
C.
Extrapolating from patients with acromegaly, the overall risk of
cancer will be higher
D.
There is no evidence that high normal IGF-1 levels are associated
with higher risk of cancer
E.
HGH treatment is contraindicated
Question 17
17. According to the American Thyroid Association guidelines
for the management of thyroid nodules, which nodule in
the different scenarios described below should have a
diagnostic FNA?
A. A 4-mm solid nodule in a patient who was
exposed to ionizing radiation 10 years ago
B. A 9-mm nodule in a low risk patient
C. An 18-mm spongiform nodule in a low risk patient
D. A purely cystic 24-mm nodule in a low risk patient
E. A 13-mm solid hypoechoic nodule in a low risk
patient
Question 18
A 17-year old girl is brought by her parents because of concern with amenorrhea. She has been a
ballet dancer since age 6 and trains for 15 hours per week. According to her mother she eats
very well. She does not have any concerns that her daughter could have bulimic practices. She
started menarche at age 13 and had about 4 periods a year until age 15 when she stopped having
menses. She is 5’ 2” tall and weighs 75 lbs. She has normal BP and heart rate. She is not
orthostatic. You do not notice any skin hyperpigmentation or pallor. She has normal Tanner
stage breast and normal pubic and axillary hair. She had withdrawal menses after progesterone
challenge.
What do you expect to find in this young woman?
A. Elevated serum leptin level
B. Decreased mean GH and IGF-1 levels
C. Elevated plasma cortisol
D. Elevated plasma DHEAS
E. Elevated FSH and LH
Question 19
43 yo female had a pelvic ultrasound for pain and was found to have a left
adnexal mass. She underwent left oophorectomy and was found to have a
peritoneal mass which was excised. Pathology revealed struma ovarii in the
ovarian lesion and benign thyroid tissue in the peritoneal lesion.
She underwent laparoscopy which detected multiple peritoneal lesions which
all contained “benign” thyroid tissue on biopsy.
Lab work:
TSH 0.675 mU/L (normal 0.4-5.5)
Thyroglobulin 38.4 ng/mL (normal 0.8-49)
Thyroglobulin Antibody titer 4.2 IU/mL (normal <14.4)
She underwent a total thyroidectomy to allow for scanning and treatment of
the peritoneal lesions. She was found to have a 0.1-cm papillary thyroid
carcinoma, classical type with focal tall cell changes.
Question 19
Question 19
What the correct statement about the patient’s case?
A.
The patient has metastatic papillary thyroid carcinoma
B.
The patient has peritoneal strumosis
C.
The patient should have the peritoneal lesions resected
D.
The patient should receive chemotherapy
E.
None of the above is correct
Question 20
What is the correct statement regarding “thyroid”
changes during treatment with SUNITINIB?
A.
Hypothyroidism is always preceded by a hyperthyroid destructive
phase
B.
The risk of developing thyroid dysfunction decreases with time as
the patient continues on treatment cycles
C.
The increase in thyroid hormone requirement during sunitinib
treatment may be due to inhibition of MCT8
D.
Sunitinib may inhibit type 3 deiodinase activity in the liver
E.
None of the above is correct
Thank you